BioCryst Pharmaceuticals | BCRX - Attività Correnti





Attività Correnti Cambiamento Data
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
Chugai Pharma JPY 1.64T 65.29B 2026-09
Daiichi Sankyo JPY 2.38T 150.33B 2026-09
DBV Technologies USD 189.6M 12.3M 2026-09
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Glaxosmithkline GBP 17.9B 134M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Novavax USD 707.96M 63.14M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09